Home/Filings/4/0001209191-17-009299
4//SEC Filing

Juno Therapeutics, Inc. 4

Accession 0001209191-17-009299

CIK 0001594864operating

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 7:36 PM ET

Size

7.2 KB

Accession

0001209191-17-009299

Insider Transaction Report

Form 4
Period: 2017-02-07
Levitsky Hyam
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-02-07+68,18268,182 total
    Exercise: $20.76Exp: 2027-02-06Common Stock (68,182 underlying)
  • Award

    Common Stock

    2017-02-07+14,634131,334 total
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") granted pursuant to the 2014 Equity Incentive Plan. 25% of the RSUs vest on each anniversary of February 7, 2017.
  • [F2]1/48th of the shares subject to the option vests and becomes exercisable on March 7, 2017 and 1/48th of the shares subject to the option vests and becomes exercisable monthly thereafter.

Issuer

Juno Therapeutics, Inc.

CIK 0001594864

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001594864

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:36 PM ET
Size
7.2 KB